International
The Morning Science

What science found today

‹
 

Policy

China could ‘corner’ biopharmaceutical sector with new plan, US panel warns

BioPharma Dive · By Jonathan Gardner ·

China could ‘corner’ biopharmaceutical sector with new plan, US panel warns

The Brief

  • A US commission warned of an overdependence on China in biopharmaceuticals.
  • The commission urged US lawmakers to act quickly to prevent that overdependence.
  • The commission said American patients could become vulnerable to supply chain weaponization.

Why it matters

Heavy reliance on a single foreign country for drug supply chains could expose patients and producers to disruption or political pressure, which matters for anyone tracking medicine supply and biotech policy.

Who’s affected

  • patients who depend on pharmaceutical supply chains
  • biopharmaceutical companies and their suppliers
  • US lawmakers and policymakers

A commission called on U.S. lawmakers to act quickly to prevent an “overdependence” on China that could leave American patients “vulnerable to supply chain weaponization.”

Timeline

  1. US commission warns of overdependence on China in biopharmaceuticals and urges lawmakers to act quickly

  2. BioPharma Dive - Latest News

    China could ‘corner’ biopharmaceutical sector with new plan, US panel warns

How do you feel about this?

0 Comments

    China could ‘corner’ biopharmaceutical sector with new plan, US panel warns – The Morning Science